Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors von Facchinetti, Francesco, Hollebecque, Antoine, Bahleda, Rastislav, Loriot, Yohann, Olaussen, Ken A., Massard, Christophe, Friboulet, Luc

Volltext

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer von Devarakonda, Siddhartha, Rotolo, Federico, Tsao, Ming-Sound, Lanc, Irena, Brambilla, Elisabeth, Masood, Ashiq, Olaussen, Ken A, Fulton, Robert, Sakashita, Shingo, McLeer-Florin, Anne, Ding, Keyue, Le Teuff, Gwénaël, Shepherd, Frances A, Pignon, Jean-Pierre, Graziano, Stephen L, Kratzke, Robert, Soria, Jean-Charles, Seymour, Lesley, Govindan, Ramaswamy, Michiels, Stefan

Volltext

ERCC1 and RRM1: Ready for Prime Time? von Besse, Benjamin, Olaussen, Ken A, Soria, Jean-Charles

Volltext

Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI? von Recondo, Gonzalo, Facchinetti, Francesco, Olaussen, Ken A., Besse, Benjamin, Friboulet, Luc

Volltext

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy von Olaussen, Ken A, Dunant, Ariane, Fouret, Pierre, Brambilla, Elisabeth, André, Fabrice, Haddad, Vincent, Taranchon, Estelle, Filipits, Martin, Pirker, Robert, Popper, Helmut H, Stahel, Rolf, Sabatier, Laure, Pignon, Jean-Pierre, Tursz, Thomas, Le Chevalier, Thierry, Soria, Jean-Charles

Volltext

Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway von Vitale, Ilio, Galluzzi, Lorenzo, Vivet, Sonia, Nanty, Lisa, Dessen, Philippe, Senovilla, Laura, Olaussen, Ken A, Lazar, Vladimir, Prudhomme, Michelle, Golsteyn, Roy M, Castedo, Maria, Kroemer, Guido

Volltext

Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer von Michels, Judith, Vitale, Ilio, Senovilla, Laura, Enot, David P., Garcia, Pauline, Lissa, Delphine, Olaussen, Ken A., Brenner, Catherine, Soria, Jean-Charles, Castedo, Maria, Kroemer, Guido

Volltext

A novel antibody-based approach to detect the functional ERCC1-202 isoform von Kuo, Mei-Shiue, Adam, Julien, Dorvault, Nicolas, Robin, Angélique, Friboulet, Luc, Soria, Jean-Charles, Olaussen, Ken A.

Volltext

MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer von KAMAL, Nermine S, SORIA, Jean-Charles, LE CHEVALIER, Thierry, FILIPITS, Martin, FOURET, Pierre, MENDIBOURE, Jean, PLANCHARD, David, OLAUSSEN, Ken A, ROUSSEAU, Vanessa, POPPER, Helmut, PIRKER, Robert, BERTRAND, Pascale, DUNANT, Ariane

Volltext

A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib von DE LA MOTTE ROUGE, Thibault, GALLUZZI, Lorenzo, PIERRON, Gerard, PINNA, Guillaume, ARAUJO, Natalia, HAREL-BELAN, Annick, ARMAND, Jean-Pierre, TAI WAI WONG, SORIA, Jean Charles, KROEMER, Guido, OLAUSSEN, Ken A, ZERMATI, Yael, TASDEMIR, Ezgi, ROBERT, Thomas, RIPOCHE, Hugues, LAZAR, Vladimir, DESSEN, Philippe, HARPER, Francis

Volltext

Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer von Facchinetti, Francesco, Hollebecque, Antoine, Braye, Floriane, Vasseur, Damien, Pradat, Yoann, Bahleda, Rastislav, Pobel, Cedric, Bigot, Ludovic, Deas, Olivier, Florez Arango, Juan David, Guaitoli, Giorgia, Mizuta, Hayato, Combarel, David, Tselikas, Lambros, Michiels, Stefan, Nikolaev, Sergey I, Scoazec, Jean-Yves, Ponce-Aix, Santiago, Besse, Benjamin, Olaussen, Ken A, Loriot, Yohann, Friboulet, Luc

Volltext

DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade von Touat, Mehdi, Sourisseau, Tony, Dorvault, Nicolas, Chabanon, Roman M, Garrido, Marlène, Morel, Daphné, Krastev, Dragomir B, Bigot, Ludovic, Adam, Julien, Frankum, Jessica R, Durand, Sylvère, Pontoizeau, Clement, Souquère, Sylvie, Kuo, Mei-Shiue, Sauvaigo, Sylvie, Mardakheh, Faraz, Sarasin, Alain, Olaussen, Ken A, Friboulet, Luc, Bouillaud, Frédéric, Pierron, Gérard, Ashworth, Alan, Lombès, Anne, Lord, Christopher J, Soria, Jean-Charles, Postel-Vinay, Sophie

Volltext

Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non–small cell lung cancer von Facchinetti, Francesco, Lacroix, Ludovic, Mezquita, Laura, Scoazec, Jean-Yves, Loriot, Yohann, Tselikas, Lambros, Gazzah, Anas, Rouleau, Etienne, Adam, Julien, Michiels, Stefan, Massard, Christophe, André, Fabrice, Olaussen, Ken A., Vassal, Gilles, Howarth, Karen, Besse, Benjamin, Soria, Jean-Charles, Friboulet, Luc, Planchard, David

Volltext

ERCC1-Specific Immunostaining in Non–Small-Cell Lung Cancer von Fouret, Pierre, Olaussen, Ken A, Kroemer, Guido

Volltext

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma von Leduc, Charlotte, Adam, Julien, Louvet, Emilie, Sourisseau, Tony, Dorvault, Nicolas, Bernard, Marine, Maingot, Elodie, Faivre, Laura, Cassin-Kuo, Mei-Shiue, Boissier, Emilie, Dessoliers, Marie-Charlotte, Robin, Angélique, Casiraghi, Odile, Even, Caroline, Temam, Stéphane, Olaussen, Ken A, Soria, Jean-Charles, Postel-Vinay, Sophie

Volltext

Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance von Sourisseau, Tony, Helissey, Carole, Lefebvre, Céline, Ponsonnailles, Florence, Malka-Mahieu, Hélène, Olaussen, Ken A, André, Fabrice, Vagner, Stephan, Soria, Jean-Charles

Volltext

Abstract 5006: Docetaxel-platinum-fluorouracil (TPF) induction chemotherapy increases PD-L1 positivity and CD8+ / FOXP3+ immune infiltrates in advanced head and neck squamous cell... von Leduc, Charlotte, Adam, Julien, Louvet, Emilie, Bernard, Marine, Maingot, Elodie, Even, Caroline, Olaussen, Ken A., Temam, Stéphane, Soria, Jean-Charles, Postel-Vinay, Sophie

Volltext

PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outs von Olaussen, Ken A, Adam, Julien, Vanhecke, Elsa, Vielh, Philippe, Pirker, Robert, Friboulet, Luc, Popper, Helmut, Robin, Angélique, Commo, Fréderic, Thomale, Jürgen, Kayitalire, Louis, Filipits, Martin, Le Chevalier, Thierry, André, Fabrice, Brambilla, Elisabeth, Soria, Jean-Charles

Volltext

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy von Recondo, Gonzalo, Mahjoubi, Linda, Maillard, Aline, Loriot, Yohann, Bigot, Ludovic, Facchinetti, Francesco, Bahleda, Rastislav, Gazzah, Anas, Hollebecque, Antoine, Mezquita, Laura, Planchard, David, Naltet, Charles, Lavaud, Pernelle, Lacroix, Ludovic, Richon, Catherine, Lovergne, Aurelie Abou, De Baere, Thierry, Tselikas, Lambros, Deas, Olivier, Nicotra, Claudio, Ngo-Camus, Maud, Frias, Rosa L., Solary, Eric, Angevin, Eric, Eggermont, Alexander, Olaussen, Ken A., Vassal, Gilles, Michiels, Stefan, Andre, Fabrice, Scoazec, Jean-Yves, Massard, Christophe, Soria, Jean-Charles, Besse, Benjamin, Friboulet, Luc

Volltext

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer von Recondo, Gonzalo, Mezquita, Laura, Facchinetti, Francesco, Planchard, David, Gazzah, Anas, Bigot, Ludovic, Rizvi, Ahsan Z., Frias, Rosa L., Thiery, Jean Paul, Scoazec, Jean-Yves, Sourisseau, Tony, Howarth, Karen, Deas, Olivier, Samofalova, Dariia, Galissant, Justine, Tesson, Pauline, Braye, Floriane, Naltet, Charles, Lavaud, Pernelle, Mahjoubi, Linda, Abou Lovergne, Aurelie, Vassal, Gilles, Bahleda, Rastilav, Hollebecque, Antoine, Nicotra, Claudio, Ngo-Camus, Maud, Michiels, Stefan, Lacroix, Ludovic, Richon, Catherine, Auger, Nathalie, De Baere, Thierry, Tselikas, Lambros, Solary, Eric, Angevin, Eric, Eggermont, Alexander M., Andre, Fabrice, Massard, Christophe, Olaussen, Ken A., Soria, Jean-Charles, Besse, Benjamin, Friboulet, Luc

Volltext